C([O:3][C:4](=[O:20])[CH2:5][S:6][C:7]1[NH:11][C:10]2[C:12]([CH:18]=[O:19])=[C:13]([O:16]C)[CH:14]=[CH:15][C:9]=2[N:8]=1)C.B(Br)(Br)Br>ClCCl>[CH:18]([C:12]1[C:10]2[NH:11][C:7]([S:6][CH2:5][C:4]([OH:20])=[O:3])=[N:8][C:9]=2[CH:15]=[CH:14][C:13]=1[OH:16])=[O:19]To a solution of (7-Formyl-6-methoxy-1H-benzoimidazol-2-ylsulfanyl)-acetic acid ethyl ester (500 mg, 1.88 mmol) in abs. dichloromethane (40 mL) stirred under argon at −78° C., boron tribromide (723 μl, 1.88 g, 7.52 mmol) was added dropwise and the mixture was warmed to room temperature and stirred for 2 h. An additional portion of boron tribromide (723 μl, 1.88 g, 7.52 mmol) was added at −78° C. and stirred for 2 h at room temperature. The mixture was quenched by slow addition of 120 mL. of water. The mixture was evaporated to dryness, suspended in boiling ethyl acetate, and the solid was filtered off. The filtrate was evaporated and triturated with diethyl ether. The title compound (220 mg, 0.87 mmol, 46%) was obtained as a light orange powder.